Stay updated on HBI-8000 Combo with Nivolumab in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the HBI-8000 Combo with Nivolumab in Solid Tumors Clinical Trial page.

Latest updates to the HBI-8000 Combo with Nivolumab in Solid Tumors Clinical Trial page
- Check3 days agoChange Detected- The page now shows Revision: v3.6.5 instead of Revision: v3.6.4. This reflects a minor revision update to the page template or CMS, with no changes to the study content.SummaryDifference0.0%

- Check10 days agoChange DetectedThe page now includes a Results Posted entry dated 2026-07-30. It also updates eligibility criteria sections and key milestones (start date 2016-08-18, primary completion 2023-12-12).SummaryDifference5%

- Check17 days agoChange DetectedThe page revision tag changed from v3.6.3 to v3.6.4, signaling a deployment of an updated page version. This reflects a small maintenance update to the study record rather than changes to the study content.SummaryDifference0.1%

- Check24 days agoNo Change Detected
- Check39 days agoChange DetectedThe page’s revision tag updated from v3.6.2 to v3.6.3, indicating a new build of the study page. This update concerns only version metadata and does not modify study information presented to users.SummaryDifference0.1%

- Check46 days agoChange DetectedThe page revision label changed from v3.6.0 to v3.6.2, indicating a new build of the page; no study content differences are evident.SummaryDifference0.1%

- Check61 days agoChange DetectedRecruitment status updated to no longer enroll; new help/navigation sections added and the Intervention/Treatment header updated, along with a new revision label.SummaryDifference0.4%

Stay in the know with updates to HBI-8000 Combo with Nivolumab in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the HBI-8000 Combo with Nivolumab in Solid Tumors Clinical Trial page.